Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
The STAND Against Emerging Opioids Act would add tianeptine to the list of federally controlled substances by classifying it as a Schedule III drug under the Controlled Substances Act. Tianeptine is a substance increasingly sold as an over-the-counter supplement or "gas station drug" that produces opioid-like effects and has raised public health concerns about addiction and misuse. The bill would prohibit unauthorized possession, distribution, and sale of tianeptine and its chemical variants nationwide, bringing it under the same regulatory framework as other prescription medications with abuse potential. The scheduling would take effect 90 days after the bill becomes law, giving the pharmaceutical industry and retailers a transition period to adjust their operations. The legislation targets a growing public health threat by preventing the unregulated sale of this drug while it gains popularity as a legal alternative to controlled opioids.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.